(NASDAQ: SLGL) Sol Gel Technologies's forecast annual revenue growth rate of 75.66% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Sol Gel Technologies's revenue in 2024 is $1,554,000.On average, 2 Wall Street analysts forecast SLGL's revenue for 2024 to be $64,768,967, with the lowest SLGL revenue forecast at $62,679,645, and the highest SLGL revenue forecast at $66,858,288. On average, 1 Wall Street analysts forecast SLGL's revenue for 2025 to be $169,931,482, with the lowest SLGL revenue forecast at $169,931,482, and the highest SLGL revenue forecast at $169,931,482.
In 2026, SLGL is forecast to generate $225,646,722 in revenue, with the lowest revenue forecast at $225,646,722 and the highest revenue forecast at $225,646,722.